Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2.6M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 45 most recent Form 4 transactions.
| Aug 29, 2025 | ITOS | iTeos Therapeutics, Inc. | DTOISS◆ | 185,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 29, 2025 | ITOS | iTeos Therapeutics, Inc. | DTOISS◆ | 17,544 | — | — | — | Open the original filing on SEC.gov |
| Aug 29, 2025 | ITOS | iTeos Therapeutics, Inc. | DTOISS◆ | 50,128 | — | — | — | Open the original filing on SEC.gov |
| Aug 29, 2025 | ITOS | iTeos Therapeutics, Inc. | DTOISS◆ | 94,336 | — | — | — | Open the original filing on SEC.gov |
| Aug 29, 2025 | ITOS | iTeos Therapeutics, Inc. | DTOISS◆ | 444,815 | — | — | — | Open the original filing on SEC.gov |
| Aug 29, 2025 | ITOS | iTeos Therapeutics, Inc. | DTOISS◆ | 14,185 | — | — | — | Open the original filing on SEC.gov |
| Aug 29, 2025 | ITOS | iTeos Therapeutics, Inc. | UTENDR | 94,027 | — | — | -100.0% | Open the original filing on SEC.gov |
| Aug 29, 2025 | ITOS | iTeos Therapeutics, Inc. | UTENDR | 153,903 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jul 16, 2025 | VOR | Vor Biopharma Inc. | AGRANT◆ | 60,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 10, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷◆ | 94,027 | — | — | — | Open the original filing on SEC.gov |
| Jun 10, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷◆ | 18,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 10, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷◆ | 43,883 | — | — | — | Open the original filing on SEC.gov |
| Jun 10, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷◆ | 8,400 | — | — | — | Open the original filing on SEC.gov |
| Jun 10, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷ | 94,027 | $4.30 | $404.3K | — | Open the original filing on SEC.gov |
| Jun 10, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷ | 18,000 | $4.30 | $77.4K | +13.2% | Open the original filing on SEC.gov |
| Jun 10, 2025 | ITOS | iTeos Therapeutics, Inc. | SSELL◷ | 43,883 | $10.02 | $439.7K | -100.0% | Open the original filing on SEC.gov |
| Jun 10, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷ | 43,883 | $4.30 | $188.7K | — | Open the original filing on SEC.gov |
| Jun 10, 2025 | ITOS | iTeos Therapeutics, Inc. | SSELL◷ | 8,400 | $10.02 | $84.2K | -5.8% | Open the original filing on SEC.gov |
| Jun 10, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷ | 8,400 | $4.30 | $36.1K | +6.2% | Open the original filing on SEC.gov |
| Jun 9, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷◆ | 43,882 | — | — | — | Open the original filing on SEC.gov |
| Jun 9, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷◆ | 8,400 | — | — | — | Open the original filing on SEC.gov |
| Jun 9, 2025 | ITOS | iTeos Therapeutics, Inc. | SSELL◷ | 43,882 | $10.03 | $440.1K | -100.0% | Open the original filing on SEC.gov |
| Jun 9, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷ | 43,882 | $4.30 | $188.7K | — | Open the original filing on SEC.gov |
| Jun 9, 2025 | ITOS | iTeos Therapeutics, Inc. | SSELL◷ | 8,400 | $10.03 | $84.3K | -5.8% | Open the original filing on SEC.gov |
| Jun 9, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷ | 8,400 | $4.30 | $36.1K | +6.2% | Open the original filing on SEC.gov |
| Jun 6, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷◆ | 43,882 | — | — | — | Open the original filing on SEC.gov |
| Jun 6, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷◆ | 8,400 | — | — | — | Open the original filing on SEC.gov |
| Jun 6, 2025 | ITOS | iTeos Therapeutics, Inc. | SSELL◷ | 43,882 | $10.21 | $448K | -100.0% | Open the original filing on SEC.gov |
| Jun 6, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷ | 43,882 | $4.30 | $188.7K | — | Open the original filing on SEC.gov |
| Jun 6, 2025 | ITOS | iTeos Therapeutics, Inc. | SSELL◷ | 8,400 | $10.21 | $85.8K | -5.8% | Open the original filing on SEC.gov |
| Jun 6, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷ | 8,400 | $4.30 | $36.1K | +6.2% | Open the original filing on SEC.gov |
| Jun 5, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷◆ | 43,882 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷◆ | 8,400 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | ITOS | iTeos Therapeutics, Inc. | SSELL◷ | 43,882 | $10.15 | $445.4K | -100.0% | Open the original filing on SEC.gov |
| Jun 5, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷ | 43,882 | $4.30 | $188.7K | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | ITOS | iTeos Therapeutics, Inc. | SSELL◷ | 8,400 | $10.15 | $85.3K | -5.8% | Open the original filing on SEC.gov |
| Jun 5, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷ | 8,400 | $4.30 | $36.1K | +6.2% | Open the original filing on SEC.gov |
| Jun 4, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷◆ | 43,883 | — | — | — | Open the original filing on SEC.gov |
| Jun 4, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷◆ | 8,400 | — | — | — | Open the original filing on SEC.gov |
| Jun 4, 2025 | ITOS | iTeos Therapeutics, Inc. | SSELL◷ | 43,883 | $10.10 | $443.2K | -100.0% | Open the original filing on SEC.gov |
| Jun 4, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷ | 43,883 | $4.30 | $188.7K | — | Open the original filing on SEC.gov |
| Jun 4, 2025 | ITOS | iTeos Therapeutics, Inc. | SSELL◷ | 8,400 | $10.10 | $84.8K | -5.8% | Open the original filing on SEC.gov |
| Jun 4, 2025 | ITOS | iTeos Therapeutics, Inc. | MEXER◷ | 8,400 | $4.30 | $36.1K | +6.2% | Open the original filing on SEC.gov |